News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,675 Results
Type
Article (87735)
Company Profile (824)
Press Release (778097)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (233166)
Career Advice (4143)
Deals (39830)
Drug Delivery (144)
Drug Development (91350)
Employer Resources (203)
FDA (18348)
Job Trends (17414)
News (397686)
Policy (39946)
Tag
Academia (3006)
Academic (2)
Accelerated approval (25)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (167)
Alzheimer's disease (1755)
Antibody-drug conjugate (ADC) (301)
Approvals (18438)
Artificial intelligence (577)
Autoimmune disease (129)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (186)
Biotechnology (488)
Bladder cancer (149)
Brain cancer (61)
Breast cancer (599)
Cancer (4622)
Cardiovascular disease (406)
Career advice (3565)
Career pathing (40)
CAR-T (288)
CDC (59)
Celiac Disease (1)
Cell therapy (781)
Cervical cancer (36)
Clinical research (76467)
Collaboration (1580)
Company closure (5)
Compensation (1055)
Complete response letters (65)
COVID-19 (2974)
CRISPR (93)
C-suite (732)
Cystic fibrosis (147)
Data (5748)
Decentralized trials (2)
Denatured (68)
Depression (131)
Diabetes (491)
Diagnostics (7163)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (270)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (221)
Earnings (99874)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134468)
Executive appointments (1009)
FDA (21162)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1427)
Gene editing (201)
Generative AI (60)
Gene therapy (617)
GLP-1 (1081)
Government (5417)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (80)
Immunology and inflammation (272)
Immuno-oncology (35)
Indications (75)
Infectious disease (3242)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (216)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (652)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (642)
Lymphoma (357)
Machine learning (40)
Management (66)
Manufacturing (735)
MASH (164)
Medical device (14965)
Medtech (15004)
Mergers & acquisitions (22861)
Metabolic disorders (1281)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (321)
Neuropsychiatric disorders (85)
Neuroscience (2943)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (613)
Opinion (326)
Ovarian cancer (152)
Pain (184)
Pancreatic cancer (198)
Parkinson's disease (272)
Partnered (34)
Patents (465)
Patient recruitment (396)
Peanut (58)
People (66612)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23613)
Phase II (33193)
Phase III (25011)
Pipeline (3778)
Policy (318)
Postmarket research (3554)
Preclinical (10658)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (796)
Real estate (7435)
Recruiting (80)
Regulatory (28501)
Reports (65)
Research institute (2715)
Resumes & cover letters (651)
Rett syndrome (23)
RNA editing (16)
RSV (82)
Schizophrenia (147)
Series A (234)
Series B (177)
Service/supplier (30)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (116)
Vaccines (1100)
Venture capital (76)
Weight loss (431)
Women's health (76)
Worklife (21)
Date
Today (113)
Last 7 days (671)
Last 30 days (2864)
Last 365 days (33355)
2025 (32211)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (85)
Alaska (7)
Arizona (325)
Arkansas (14)
Asia (51293)
Australia (9013)
California (10740)
Canada (3150)
China (1041)
Colorado (453)
Connecticut (479)
Delaware (320)
Europe (117928)
Florida (1574)
Georgia (348)
Hawaii (3)
Idaho (68)
Illinois (884)
India (62)
Indiana (518)
Iowa (22)
Japan (374)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1394)
Massachusetts (7967)
Michigan (339)
Minnesota (623)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2938)
New Mexico (32)
New York (2877)
North Carolina (1527)
North Dakota (10)
Northern California (5053)
Ohio (327)
Oklahoma (22)
Oregon (52)
Pennsylvania (2180)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4122)
Tennessee (165)
Texas (1687)
United States (39110)
Utah (323)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (904)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
There are 866,675 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hemostemix Grants Stock Options
December 11, 2025
·
7 min read
Press Releases
Hemostemix CEO Introduces Conformal Consciousness Hypothesis A = E/(hv)
Thomas Smeenk, BA, unveils a proposed conformal invariant, A = E/(hv), explored as a potential bridge between General Relativity, Quantum Mechanics, cosmology, and string theory.
December 11, 2025
·
9 min read
Press Releases
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update
December 11, 2025
·
13 min read
Press Releases
Mabylon AG Initiates Phase I Clinical Trial of Lead Compound MY006 for the Treatment of Peanut Allergy
- First study participant dosed in U.S. trial with healthy volunteers and patients with peanut allergy - Novel, human-derived, half-life extended tri-specific monoclonal antibody to prevent allergic reactions
December 11, 2025
·
1 min read
Press Releases
InflaRx Announces International Nonproprietary Name of “Izicopan” for INF904
December 11, 2025
·
9 min read
Press Releases
Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day
December 11, 2025
·
7 min read
Press Releases
Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome
December 11, 2025
·
11 min read
Press Releases
Autobahn Labs Forms Strategic Partnership with Astellas to Accelerate Academic Discoveries into New Medicines
December 11, 2025
·
2 min read
Press Releases
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas
December 11, 2025
·
6 min read
Press Releases
Plus Therapeutics Expands CNSide Assay Platform to State of California
December 11, 2025
·
5 min read
1 of 86,668
Next
